BIOMAT Database Logo BIOMAT Database Logo

Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. 1991

J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510.

UI MeSH Term Description Entries
D008297 Male Males
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D010617 Phenanthridines
D002522 Chlorocebus aethiops A species of CERCOPITHECUS containing three subspecies: C. tantalus, C. pygerythrus, and C. sabeus. They are found in the forests and savannah of Africa. The African green monkey is the natural host of SIMIAN IMMUNODEFICIENCY VIRUS and is used in AIDS research. African Green Monkey,Cercopithecus aethiops,Cercopithecus griseoviridis,Cercopithecus griseus,Cercopithecus pygerythrus,Cercopithecus sabeus,Cercopithecus tantalus,Chlorocebus cynosuros,Chlorocebus cynosurus,Chlorocebus pygerythrus,Green Monkey,Grivet Monkey,Lasiopyga weidholzi,Malbrouck,Malbrouck Monkey,Monkey, African Green,Monkey, Green,Monkey, Grivet,Monkey, Vervet,Savanah Monkey,Vervet Monkey,Savannah Monkey,African Green Monkey,Chlorocebus cynosuro,Green Monkey, African,Green Monkeys,Grivet Monkeys,Malbrouck Monkeys,Malbroucks,Monkey, Malbrouck,Monkey, Savanah,Monkey, Savannah,Savannah Monkeys,Vervet Monkeys
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015259 Dopamine Agents Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons. Dopamine Drugs,Dopamine Effect,Dopamine Effects,Dopaminergic Agents,Dopaminergic Drugs,Dopaminergic Effect,Dopaminergic Effects,Agents, Dopamine,Agents, Dopaminergic,Drugs, Dopamine,Drugs, Dopaminergic,Effect, Dopamine,Effect, Dopaminergic,Effects, Dopamine,Effects, Dopaminergic
D015632 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease. MPTP,N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

Related Publications

J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Dihydrexidine, a full D1 dopamine receptor agonist, induces rotational asymmetry in hemiparkinsonian monkeys.
August 1995, Pharmacology, biochemistry, and behavior,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Dihydrexidine--the first full dopamine D1 receptor agonist.
January 2004, CNS drug reviews,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
July 1992, The Journal of pharmacology and experimental therapeutics,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease.
January 1998, Clinical neuropharmacology,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Dihydrexidine: a new potent peripheral dopamine D1 receptor agonist.
April 1993, European journal of pharmacology,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Effects of dihydrexidine, a full dopamine D-1 receptor agonist, on delayed response performance in chronic low dose MPTP-treated monkeys.
November 1994, Brain research,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist.
November 1991, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.
January 1993, Advances in neurology,
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
In vivo PET studies of the dopamine D1 receptors in rhesus monkeys with long-term MPTP-induced Parkinsonism.
May 2002, Synapse (New York, N.Y.),
J R Taylor, and M S Lawrence, and D E Redmond, and J D Elsworth, and R H Roth, and D E Nichols, and R B Mailman
The discriminative properties of the D1 dopamine agonist dihydrexidine in the rat.
May 1995, Psychopharmacology,
Copied contents to your clipboard!